Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 946-819-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from 2017-04-13 to 2017-05-23
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- 2001
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Version / remarks:
- 2008
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- disodium 3-[(1E)-2-(4-dodecylphenyl)diazen-1-yl]-5-acetamido-4-hydroxynaphthalene-2,7-disulfonate
- EC Number:
- 946-819-5
- Molecular formula:
- Not applicable for UVCB substance
- IUPAC Name:
- disodium 3-[(1E)-2-(4-dodecylphenyl)diazen-1-yl]-5-acetamido-4-hydroxynaphthalene-2,7-disulfonate
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Remarks:
- Hsd
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
-Source: Envigo RMS s.r.l., San Pietro al Natisone (UD), Italy
-Females nulliparous and non-pregnant: yes
-Age at study initiation: 7 weeks old
-Weight at study initiation: 168.3-189.3 grams
-Fasting period before study: food was removed from the cages overnight prior to dosing (Day -1) and was made available approximately 4 hours after dosing.
-Animals per cage 3 during the study; up to 5 during acclimatisation
-Housing: Polisulphone solid bottomed cages measuring 59.5×38×20 cm with nesting material provided into suitable bedding bags
-Diet :4 RF 18 (Mucedola S.r.l., Via G. Galilei, 4, 20019, Settimo Milanese (MI) Italy) ad libitum
-Water: drinking water supplied to each cage via a water bottle ad libitum
-Acclimation period: At least 5 days
-Veterinary health check: During acclimatisation period
ENVIRONMENTAL CONDITIONS
-Temperature: 22 °C ± 2 °C
-Humidity: 55 % ± 15 %
-Air changes: Approximately 15 to 20 air changes per hour
-Photoperiod: Artifi cial (fl uorescent tubes), daily light /dark cycle of 12/12 hours
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
-Amount of vehicle: the formulated test item was administered at a dose volume of 10 ml/kg using a plastic feeding tube attached to a graded syringe.
- Doses:
- 300, 2000 mg/kg b.w
- No. of animals per sex per dose:
- Step 1: 3 females at 300 mg/kg b.w
Step 2: 3 females at 300 mg/kg b.w
Step 3: 3 females at 2000 mg/kg b.w
Step 4: 3 females at 2000 mg/kg b.w - Control animals:
- no
- Details on study design:
- -Duration of observation period following administration: 14 days
-Frequency of observation mortality and morbidity: throughout the study, all animals were checked twice daily.
-Frequency of observations:
Animals were observed for clinical signs as indicated below:
Day of dosing:
· Session 1: on dosing
· Session 2: approximately 0.5 hour after dosing
· Session 3: approximately 2 hours after dosing
· Session 4: approximately 4 hours after dosing
Daily thereafter for a total of 14 days
-Frequency of and weighing: all animals were weighed at allocation to the study (Day -1), on the day of dosing (Day 1) and on Days 2, 8 and 15.
-Necropsy of survivors performed: yes, all animals were sacrificed by carbon dioxide narcosis.
Necropsy was carried out on all animals (gross necropsy examination for both external and internal abnormalities, with particular attention to the gastro-intestinal tract).
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occurred
- Clinical signs:
- other: Only violet faeces in cage were observed at 4 hours after dosing in the first group of animals initially dosed at 300 mg /kg (Group 2, Step 1). In addition, violet staining in cage was recorded at 4 hours after dosing. In the secondo group at the same dos
- Gross pathology:
- No abnormalities were observed at necropsy examination performed at the end of the observation period on animals of both groups receiving 300 mg/kg and only red staining on the tail was observed in all animals dosed at 2000 mg/kg.
Applicant's summary and conclusion
- Interpretation of results:
- other: Not classified according the CLP Regulation (EC 1272/2008)
- Conclusions:
- The acute toxicity expected (ATE) of the test item was found to be greater than 2000 mg/kg body weight.
- Executive summary:
The acute toxicity of test item was investigated following a single oral administration to the Sprague Dawley rat, followed by a 14-day observation period. The test was performed according to the OECD 423 (2001). Two groups, each of 3 female animals, were initially dosed at 300 mg /kg. A third group, similarly composed, was dosed at 2000 mg/kg. A fourth group of 3 female animals was administered at the same dose level.
No mortality occurred at any dose levels. Only violet faeces in cage were observed at 4 hours after dosing in one group at dose 300 mg/kg bw; in the other group at same dose no clinical signs were noted. In one group at dose 2000 mg/kg bw red staining on the tail and on perigenital region in all animals was observed from Day 2 up to Day 15 of the observation period. In the other group at same dose only red staining on the tail in all animals was seen for the entire observation period. Body weight changes recorded during the study were within the expected range for this strain and age of animals. No abnormalities were observed at necropsy examination performed at the end of the observation period on animals of both groups receiving 300 mg/kg and only red staining on the tail was observed in all animals dosed at 2000 mg/kg.
These results indicate that the test item did not induce toxic effects in the rat following oral administration of a single dose at a level of 2000 mg/kg. The lack of mortality demonstrates the acute toxicity expected (ATE) to be greater than 2000 mg/kg body weight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.